Policy News
2022 ASH Advocacy Efforts Related to Sickle Cell Disease
ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...
Read more2022 ASH Advocacy Efforts to Ensure Patient Access to Care
ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...
Read more2022 Research and Public Health Funding Advocacy Highlights
ASH continues to advocate for issues impacting hematology research and practice, including research and public health funding, access to quality care for patients, physician payment and coverage for hematologists, and policy issues related to sickle...
Read more2022 Year-End Physician Payment and Coverage Advocacy Highlights
Medicare Inpatient Hospital Rule On August 1, the Centers for Medicare and Medicaid Services (CMS) issued the final Medicare Hospital Inpatient Prospective Payment System rule. Of interest and supported by ASH was the decision to implement new...
Read moreASH Meets with LA Governor Edwards on Maternal Health
On Friday, September 23, 2022, ASH members met with Louisiana Governor John Bel Edwards to discuss the impact of the ASH Annual Meeting on New Orleans and Louisiana as well as the Society’s efforts related to maternal health. ASH members in att...
Read more2021 Year End Research and Public Health Funding Advocacy Highlights
During 2021, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC),...
Read more2021 ASH Advocacy Efforts to Ensure Patient Access to Care
COVID-19 The COVID-19 crisis continues to play a significant role in ASH’s advocacy and practice-related efforts. Below is a list of ASH’s key advocacy and practice-related efforts related to COVID-19. In early March, ASH...
Read more2021 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait
In 2021, ASH continued to work with federal agencies, leaders at the United States Department of Health and Human Services (HHS) and the U.S. Congress to help enhance and expand government activities in sickle cell disease (SCD) research, training, a...
Read more2021 Year End Physician Payment and Coverage Advocacy Highlights
Medicare Inpatient Hospital Rule ASH offered comments in June on the fiscal year 2022 proposed rule for the Centers for Medicare and Medicaid Services (CMS) Inpatient Prospective Payment System (IPPS). The rule determines payment levels and related...
Read moreASH Summary on the Surprise Billing Interim Final Rule
On July 1, 2021, HHS issued an interim final rule with comment period (IFC) to begin the implementation of the No Surprises Act (NSA) which is the law banning “surprise billing” that was enacted by Congress in December 2020. NSA pro...
Read more- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10